Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
entrez:
9
2
2019
pubmed:
9
2
2019
medline:
27
2
2019
Statut:
ppublish
Résumé
Hyper-IgE syndrome (HIES) is a rare primary immunodeficiency presenting as two forms including autosomal dominant HIES (AD-HIES) and autosomal recessive HIES (AR-HIES), which are mainly caused by mutations in STAT3 and DOCK8, respectively. To date, only about 500 cases have been reported worldwide including 37 cases in China. The spectrum and prevalence of mutations and molecular pathogenesis in HIES remain poorly understood. Here we reported two Chinese children presenting clinical manifestations of HIES. Based on medical history, clinical manifestations, and laboratory findings, a diagnosis of HIES was made for both children. Targeted next-generation sequencing (NGS) identified a novel heterozygous deletion of 15 bp (c.1960_1974del, p.G654_D658del or alternatively c.1966_1980del, and p.G656_D660del), and a recurrent missense mutation (c.1144C>T, p.R382W) in STAT3 in the two patients, respectively. The two patients have been given the successful treatment of skin infections with cefaclor. Both patients have been under follow-up for more than 6 months, with no signs of recurrent infections. Our results extend the spectrum of STAT3 mutations associated with ADHIES and highlight the value of targeted NGS in confirming diagnosis of genetic disorders.
Identifiants
pubmed: 30732127
doi: 10.1097/MD.0000000000014003
pii: 00005792-201902080-00008
pmc: PMC6380800
doi:
Substances chimiques
Anti-Bacterial Agents
0
DOCK8 protein, human
0
Guanine Nucleotide Exchange Factors
0
STAT3 Transcription Factor
0
STAT3 protein, human
0
Cefaclor
69K7K19H4L
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14003Références
Nature. 1998 Jul 9;394(6689):145-51
pubmed: 9671298
J Clin Immunol. 2017 Feb;37(2):166-179
pubmed: 28197791
J Allergy Clin Immunol. 2009 Dec;124(6):1289-302.e4
pubmed: 20004785
Medicine (Baltimore). 2012 Jul;91(4):e1-e19
pubmed: 22751495
N Engl J Med. 2007 Oct 18;357(16):1608-19
pubmed: 17881745
Medicine (Baltimore). 2018 Apr;97(14):e0215
pubmed: 29620631
N Engl J Med. 1999 Mar 4;340(9):692-702
pubmed: 10053178
Immunity. 2006 Nov;25(5):745-55
pubmed: 17088085
J Allergy Clin Immunol. 2014 May;133(5):1400-9, 1409.e1-5
pubmed: 24589341
Clin Genet. 2016 Feb;89(2):217-21
pubmed: 26293184
Blood. 2016 Dec 29;128(26):3061-3072
pubmed: 27799162
J Allergy Clin Immunol. 2008 Jul;122(1):181-7
pubmed: 18602572
J Allergy Clin Immunol. 2010 Feb;125(2):424-432.e8
pubmed: 20159255
Nature. 2007 Aug 30;448(7157):1058-62
pubmed: 17676033